US taxpayer funds flowed to Chinese entities that conducted coronavirus research before COVID pandemic: GAO

As a writer for a news site, I came across an article that grabbed my attention titled “US taxpayer funds flowed to Chinese entities that conducted coronavirus research before COVID pandemic: GAO”. According to the Government Accountability Office (GAO), US taxpayer funds were sent to Chinese entities that conducted coronavirus research before the COVID-19 pandemic. This has raised concerns about the origins of the virus and the US involvement in funding research that may have led to the outbreak.

The GAO conducted an investigation and found that between fiscal years 2014 and 2019, the National Institutes of Health (NIH) provided approximately $823 million in grants to subrecipients that worked with or were located in China. Some of the research these entities conducted included the manipulation of coronaviruses to better understand how they could impact humans.

While it’s unclear whether these specific funds were used for coronavirus research, the report notes that taxpayer-funded research in China has become a topic of concern due to the country’s lack of transparency and the potential for the research to be used for nefarious purposes.

As someone who has been following the pandemic since its onset, it is intriguing to learn about the possible connections between US government funding and coronavirus research. The article sheds light on the potential for US taxpayer funds to be used for research that has the potential to cause harm. It also highlights the need for greater scrutiny and transparency when it comes to funding research in countries that may not share the same values and priorities as the US.

In conclusion, while the article doesn’t provide concrete evidence that these funds were directly related to the COVID-19 outbreak, it does raise important questions about the role of US taxpayer funds in funding scientific research and the need for greater transparency and oversight.